Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
---|
02/22/2012 | EP0986384B1 Inhibitors of protein isoprenyl transferases |
02/22/2012 | CN102361853A Toluidine sulfonamides and their use |
02/21/2012 | US8119673 Compounds 148 |
02/21/2012 | US8119672 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
02/21/2012 | US8119631 Inhibitors of interleukin-1β converting enzyme |
02/21/2012 | CA2444031C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
02/15/2012 | EP1963259B1 Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease |
02/15/2012 | EP1877389B1 Synthesis of cyclen derivatives |
02/15/2012 | CN102351805A Method for preparing, separating and refining 5-amino-1H-tetrazol-1-ylacetic acid |
02/15/2012 | CN102351804A Method for recovering valsartan racemate |
02/15/2012 | CN101812029B Method for producing 5-halogenolinear alkyl tetrazole |
02/14/2012 | US8114863 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
02/09/2012 | WO2012016969A1 Highly crystalline valsartan |
02/09/2012 | CA2806657A1 Highly crystalline valsartan |
02/08/2012 | CN102010381B 一种缬沙坦制备方法的改进 Improve one method for preparing Valsartan |
02/08/2012 | CN101376637B 高立方烷二酰胺类化合物及其应用 High cubane diamide compound classes and their applications |
02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
02/02/2012 | US20120029177 Heterocycle-amino acid derivatives for targeting cancer tissue and radioactive or non-radioactive labeled compounds thereof |
02/01/2012 | EP2412789A1 Lubricant composition and use thereof |
02/01/2012 | EP1817301B1 Potentiators of glutamate receptors |
02/01/2012 | CN102341378A Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives |
01/31/2012 | US8106216 Process for the preparation of Irbesartan |
01/31/2012 | US8106082 Dual-acting antihypertensive agents |
01/26/2012 | WO2012012612A2 Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes |
01/26/2012 | US20120022268 New Salt Hydrates |
01/26/2012 | US20120021253 Lubricant composition and use thereof |
01/26/2012 | US20120020915 Compounds and Methods for Treating Cancer and Diseases of the Central Nervous System |
01/25/2012 | EP2408755A2 Psma-targeting compounds and uses thereof |
01/25/2012 | CN102329306A Biphenyl valine derivative and application thereof in preparation of medicine for prevention and/or treatment of hypertension |
01/25/2012 | CN102329276A Method for recovering valsartan mother liquid |
01/24/2012 | US8101642 3-substituted propanamine compounds |
01/24/2012 | US8101599 Pharmaceutical composition containing anti-hypertensive agents |
01/19/2012 | WO2012008435A1 Biaryl amide derivative or pharmaceutically acceptable salt thereof |
01/19/2012 | WO2011102626A3 Polyazamacrocyclic compound, and a production method and a biomedical use therefor |
01/19/2012 | US20120015990 Taspase1 inhibitors and their uses |
01/19/2012 | US20120015944 Tetrazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
01/18/2012 | EP2407461A1 Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives |
01/18/2012 | CN102321039A Synthesis of electronic chemical 5-amino tetrazole |
01/18/2012 | CN102321038A Improved valsartan preparation method |
01/18/2012 | CN101805305B 5-(2 nitro-methylene)-MTT and preparation method and application thereof |
01/12/2012 | WO2012004604A1 Tetrazole compounds as calcium channel blockers |
01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
01/12/2012 | US20120009121 Psma-targeting compounds and uses thereof |
01/12/2012 | US20120007026 Tetrazine monomers and copolymers for use in organic electronic devices |
01/11/2012 | EP2404890A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
01/05/2012 | WO2012003031A2 Alternative to tetrazene |
01/05/2012 | WO2012002189A1 Method for producing valsartan |
01/05/2012 | WO2012001694A1 Process for olmesartan medoxomil |
01/05/2012 | WO2012001484A2 An improved process for the preparation of valsartan |
01/05/2012 | US20120004420 Process for preparation of 1-alkyl-5-benzoyl-1h-tetrazole derivatives |
01/05/2012 | US20120004419 Bis-(1(2)h-tetrazol-5-yl) amine and production method therefor |
01/04/2012 | EP2402300A1 Hydroxyl compounds and compositions for cholesterol management and related uses |
01/04/2012 | EP1339663B1 Naphthalene derivatives |
01/04/2012 | CN102307847A Indanyl compounds |
01/03/2012 | US8088802 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
12/29/2011 | WO2011161945A1 Alkoxyimino derivative and pest control agent |
12/29/2011 | WO2011161076A1 Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives |
12/29/2011 | US20110319438 Novel sulfonamides as l-cpt1 inhibitors |
12/29/2011 | US20110319359 Indanyl compounds |
12/28/2011 | CN102295617A 一种电子化学品5-氨基四氮唑的精制和提纯方法 Refining and purification method of electronic chemicals 5-amino-tetrazole |
12/27/2011 | US8084619 Gas generant compositions |
12/27/2011 | US8084498 Ketone compounds and compositions for cholesterol management and related uses |
12/27/2011 | US8084467 Pyrazole derivatives as cannabinoid receptor antagonists |
12/21/2011 | EP2396301A2 Small molecule bradykinin b1 receptor antagonists |
12/21/2011 | EP2217580B1 Substituted tetrazole compounds and uses thereof |
12/20/2011 | CA2450221C Compounds for the treatment of metabolic disorders |
12/15/2011 | WO2011156655A2 Novel glp-1 receptor stabilizers and modulators |
12/15/2011 | US20110306768 Processes for the manufacture of 3--pyridine, 4-methyl-3-methylthio-5-(3-pyridyl)-l,2,4-triazole, and (1r)-1-[2-(3-methylphenyl)-2h-tetrazol-5-yl]ethanol |
12/15/2011 | US20110306542 Novel glp-1 receptor stabilizers and modulators |
12/15/2011 | US20110305666 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
12/14/2011 | EP1893582B1 Compounds, their pharmaceutical compositions and their use in treating metabolic disorders |
12/13/2011 | US8076492 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
12/13/2011 | US8076330 Dipeptidyl peptidase-IV inhibitors |
12/08/2011 | WO2011151683A1 Zn (ii) based colorimetric sensor and process for the preparation thereof |
12/08/2011 | WO2011151347A1 Gadobutrol preparation in a one-pot process by means of dmf acetal and n-methylimidazole |
12/08/2011 | US20110301196 Trypsin-like serine protease inhibitors, and their preparation and use |
12/08/2011 | US20110301180 Reducing Platelet Activation, Aggregation and Platelet-Stimulated Thrombosis or Blood Coagulation by Reducing Mitochondrial Respiration |
12/08/2011 | DE102010023105A1 Gadobutrolherstellung im Eintopfverfahren mittels DMF-acetal und N-Methylimidazol Gadobutrolherstellung one-pot method using DMF acetal and N-methylimidazole |
12/08/2011 | CA2801255A1 Gadobutrol preparation in a one-pot process by means of dmf acetal and n-methylimidazole |
12/07/2011 | EP2391610A1 Luminescent lanthanide complexes |
12/07/2011 | CN102272109A 血管内造影剂 Intravascular contrast agent |
12/07/2011 | CN101239935B 酞菁化合物及其中间体的制备方法以及这些中间体化合物 Phthalocyanine compounds and intermediates for preparing compounds and intermediates |
12/06/2011 | US8071784 Lead-free primary explosive composition and method of preparation |
12/01/2011 | US20110293553 Identification of insect attractant, arresting, and/or aggregation compounds and methods thereof |
11/30/2011 | EP2389367A1 Preparation of a lead-free primary explosive |
11/23/2011 | CN102256967A Processes for the manufacture of 3-{4-methyl-5- [ (ir) -1- (2- (3-methylphenyl) -2h-tetrazol-5-yl) -ethoxy] -4h- [1,2, 4] triazol-3-yl} -pyridine, 4-methyl-3-methylthio-5- (3- pyridyl)-l,2,4-triazole, and (ir) -1- [2- (3-methylphenyl) -2h- tetrazol-5 |
11/23/2011 | CN102250031A High-purity valsartan compound |
11/22/2011 | US8063228 Conversion of salt halides to nitrate salts |
11/22/2011 | US8063082 Certain chemical entities, compositions, and methods |
11/22/2011 | US8063032 Histamine H3 inverse agonists and antagonists and methods of use thereof |
11/17/2011 | WO2011142124A1 Photoresponsive liquid crystal compound and use thereof |
11/17/2011 | US20110281811 Use Of Leukotriene Inhibitors For Treating Lung Diseases In Prematurely Born Infants |
11/17/2011 | US20110281795 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
11/17/2011 | US20110280802 Linkers For Radiopharmaceutical Compounds |
11/17/2011 | DE102010020652A1 New compound having tetrazine anion comprising 1,2,4,5-tetrazine-3,6-bis(thiolate) or 3-mercapto-6-sulfido-3H-1,2,4, 5-tetrazin-2-ide, useful e.g. for producing 1,6-dihydro-(1,2,4,5)tetr azine-3,6-dithiol derivative |
11/16/2011 | CN102245583A Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases |
11/16/2011 | CN102241640A Synthesis method of tris-(4-tetrazolyl-phenyl)amine |
11/15/2011 | US8058301 Valsartan; hypotensive agents, cardiovascular disorders, anticholesterol agents, antilipemic agents |
11/15/2011 | CA2549995C Ketone compounds and compositions for cholesterol management and related uses |